MO-DMDD-Desktop-Banner

Drug and Medical Device Development: A Strategic Approach

Expand your medical device knowledge to achieve commercial success
Inquiring For
Total Work Experience

Program Overview: Drug and Medical Device Development

The Drug and Medical Device Development: A Strategic Approach online program from MIT xPRO equips you with a complete roadmap for creating, testing, approving, and launching new health products globally. In eight weeks, you will learn what shapes risks, quality, IP protection, clinical development, and ultimately, commercial success.

While healthcare technology is expanding rapidly, bringing a product to market demands more than technical excellence. Added layers of regulation, quality controls, and reimbursement pressures make each decision pivotal. This program equips you with the fluency to anticipate roadblocks, align clinical strategy, and design for adoption. Through real-world case studies and self-paced learning with leading experts, you will gain frameworks that strengthen product viability, accelerate pathways to approval, and position innovations for commercial success.

Hear From Faculty

“This program explodes the notion that there is ‘research’ followed by ‘development’. These forces are intertwined until you launch it.”
Faculty - MICHAEL CIMA
Professor Michael Cima
Program Director and MIT Associate Dean of Innovation

Who Is the Drug and Medical Device Development Program For?

This MIT xPRO program is for professionals in the pharmaceutical and biotechnology industries who seek a clear blueprint of the development process for medical devices and drugs, encompassing preclinical testing, clinical trials, regulatory approval, and commercialization.

A background in health sciences is beneficial for the learning journey, but not a requirement.

The program is ideal for:

  • Engineers involved in the development of new medical device products or pharmaceuticals

  • Executives in the drug and medical device development/product management field

  • Scientists and those who lead teams of scientists in R&D

  • Quality assurance and regulatory affairs professionals

  • Industry professionals making a horizontal transition into the healthcare industry

  • Entrepreneurs seeking to launch a product in the US healthcare market

  • Organizations in need of training employees and new hires on the entire process of developing medical devices and pharmaceuticals

Where Past Learners Come From

Past participants have held job functions and titles including:

Disclaimer: All product and company names are trademarks or registered trademarks of their respective holders. Use of product and company names does not imply any affiliation with or endorsement by the holders.

The list of companies is only indicative and not exhaustive.

Past participants have held job functions and titles including:

  • Owner, Director, CEO, President

  • VP, Scientific Affairs and Technical Services

  • Global Chief Clinical Officer

  • Regulatory Manager

  • Sr. Product Manager

  • Sr. Quality Systems Specialist

  • Management Consultant

  • Postdoctoral Researcher

  • Physician

  • Pharmacist

Key Takeaways

  • Gain a “big picture” perspective of the entire drug and medical device development process, from strategic planning through product commercialization

  • Understand the critical interplay between strategy and development and how they affect each other

  • Learn frameworks for assessing both the benefits and the risks associated with developing a new product in the healthcare market

  • Gain clarity around the regulatory requirements in the US market and the process for achieving approval

  • Develop professional networks for career development, industry partnerships, or strategic alliances

What You Will Learn in the Drug and Medical Device Development Program

The program curriculum features seven modules that build practical expertise in the complete drug discovery and medical device development lifecycle, including proof of concept, intellectual property, preclinical testing, diagnostics, software and AI regulation, formulation, and biologics. Through self-paced video lectures, led by renowned MIT faculty, you will learn how pharmaceutical research translates into safe, effective products that meet regulatory approval standards and market needs.

  • Recognize and minimize risks

  • Examine the strategic role of reimbursement

  • Explore how having a proof of concept test is vital to development

  • Explore the intricate dynamics of the pharmaceutical supply chain, including the influence of wholesalers, pharmacy benefit managers (PBMs), and manufacturers

  • Gain insights into risk management, strategic positioning, and navigating the complexities of bringing innovative medicines to market

  • Determine the best time to seek IP protection for ideas

  • Learn the key sections of a patent and the outcome measures of products

  • Discover the intended uses of medical products and how those are tested in clinical trials

  • Gain further understanding of patent strategies

  • Manage IP assets and navigate the complexities of product development in the pharmaceutical industry

  • Design a quality study

  • Apply quality systems to clinical trials

  • Discover important regulatory pathways

  • Gain a deeper understanding of design controls, documentation, and the intricacies of developing medical diagnostics

  • Maintain high-quality standards, adhere to regulatory requirements, and effectively manage medical device development projects

  • Evaluate diagnostics through sensitivity and specificity testing

  • Discover biomarkers, the molecular or physical indicators of disease

  • Understand what counts as wearable devices, how they are used, and what is needed to bring them to market

  • Understand the challenges and breakthroughs in ovarian cancer screening, innovative colon cancer screening methods, and the complexities of obtaining reimbursement for medical tests

  • Develop a comprehensive understanding of integrating innovative diagnostic technologies into the healthcare system, from development to market adoption

  • Review software and hardware regulations, including the FDA's General Principles of Software Validation

  • Identify key elements of drug discovery

  • Recognize the target validation process for drug development

  • Understand the essential processes of absorption, metabolism, transportation, and development in drug development and delivery

  • Explore the evolution and impact of electronic health records (EHRs) on healthcare, as well as the role of AI in medicine, offering innovative solutions for patient care and data management

  • Gain a deeper understanding of integrating technology, drug discovery, and pharmacokinetics in pharmaceutical development

  • Validate the therapeutic index of drugs

  • Understand formulations and how they ensure successful drug delivery

  • Learn about drug stability: how drugs physically and chemically break down

  • Examine parenteral products i.e., drugs injected directly into the body

  • Explore biologics i.e., drugs produced from living organisms

Note: For full details on the program modules, please download the brochure.

Case Studies and Assignment

Case Studies and Assignment - Osteoporosis and the Failed Drug Trial

Osteoporosis and the Failed Drug Trial

Play the role of a drug developer for an osteoporosis drug that has failed its clinical trial and determine why the trial failed.

Case Studies and Assignment -Corvia Medical Device

Corvia Medical Device

Assume the role of a Corvia quality engineer, and write a quality systems summary for your CEO that addresses the quality elements for this market-bound product.

Case Studies and Assignment - Disappearing Polymorphs

Disappearing Polymorphs

Imagine the role of a lab manager for a pharmaceutical company whose drug form, Ritonavir, has inexplicably changed, impacting the drug’s efficacy and the lives of numerous patients. Provide a causal factor analysis of why this drug has changed and a recommendation for this problem.

Case Studies and Assignment - Scoping a Proof of Concept

Scoping a Proof of Concept

Play the role of a drug developer working on a new pain relief drug. Identify the surrogate endpoints and the patient population for your proof of concept test to ensure your drug has its desired effects.

Case Studies and Assignment - Sensitivity and Specificity in Action — an AI Colonoscopy Diagnostic

Sensitivity and Specificity in Action — an AI Colonoscopy Diagnostic

Design an AI application to recognize at-risk polyps during a colonoscopy. Identify the important diagnostic tools to include in the criteria for designing an AI application.

Case Studies and Assignment - Death by 1000 Clicks - Where Electronic Health Records Went Wrong

Death by 1000 Clicks - Where Electronic Health Records Went Wrong 

Electronic health records are vital to the medical community, enabling physicians to collaborate by utilizing a patient's medical history and current symptoms. Review related software failures and hypothesize on resolving errors that might have resulted in success.

Compounding Pharmacies and Sterile Parenteral Products

Compounding Pharmacies and Sterile Parenteral Products

Discuss how quality systems are imperative for drugs that require intravenous administration. Provide insights on designing a sterile environment for such drugs.

Note: These are some of our learning facilitators and may change for upcoming cohorts.

Seamless Learning, Anywhere

Learn from Industry Experts

You will learn from industry experts from a wide variety of backgrounds, including leaders in healthcare, pharmaceuticals, venture capital, insurance, intellectual property law, and regulatory agencies. Featured experts include:

Noubar Afeyan
Noubar Afeyan

Senior Managing Partner, CEO, Flagship Ventures

Nikolai Begg
Nikolai Begg, PhD

Research Manager, Surgical Innovations at Medtronic

Cheryl Blanchard
Cheryl Blanchard, PhD

President and Chief Executive Officer, Microchips Biotech

Katerine Bosley
Katerine Bosley

CEO, Editas

Michael Elliott
Michael Elliott

Vice President, Immunology Scientific Innovation, Johnson & Johnson

Colin Gardner
Colin Gardner, PhD

Consultant, Formerly the VP of Global Pharmacology Development, Merck

Todd Armstrong
Todd Armstrong, PhD

JD Partner, Clark+Elbing

Elain Blais
Elain Blais

Partner, Goodwin Procter

Paolo Bonato
Paolo Bonato, PhD

Director of the Motion Analysis Laboratory, Spaulding Rehabilitation Hospital

Hongming Chen
Hongming Chen, ScD

CSO, Kala Pharmaceuticals

Robert Farra
Robert Farra

Executive VP & CTO, Microchips Biotech

Dennis Giesing
Dennis Giesing

Chief Scientific Officer, Taris Biomedical

Nathaniel Katz
Nathaniel Katz

CEO, Analgesic Solutions

Dave Mantus
Dave Mantus, PhD

Clinical and Technical Operations, Arsanis

Mark McClellan
Professor Mark McClellan, PhD, MD

Director, Duke-Margolis Institute for Health Policy, Duke University

Steven Paul
Steven Paul, MD

President and Chief Executive Officer, Voyager Therapeutics

Rene Russo
Rene Russo

PharmD, BCPS Chief Development Officer, Arsanis

David Vogel
David Vogel

President, Intertech Engineering

Janet Woodcock
Janet Woodcock

Director, Center for Drug Evaluation and Research, FDA

Mark Levin
Mark Levin

Partner, 3rd Rock Ventures

John Maraganore
John Maraganore

CEO, Alnylam

John McDonough
John McDonough

CEO, T2 Biosystem

Richard Pops
Richard Pops

CEO, Alkermes

Purnanand Sarma
Purnanand Sarma

CEO, Taris Biomedical

Tony Wood
Tony Wood

Chief Scientific Officer, R&D, GlaxoSmithKline

Note: Learning facilitators are subject to change for upcoming cohorts.

Program Highlights

MO-DMDD-PH-Icon1

Live webinars with faculty and industry experts

MO-DMDD-PH-Icon2

40+ interviews with industry leaders

MO-DMDD-PH-Icon3

Real-world case studies and practical exercises

MO-DMDD-PH-Icon4

Byte-sized content for flexible learning

MO-DMDD-PH-Icon5

Certificate of completion and 4.8 CEUs from MIT xPRO

MO-DMDD-PH-Icon6

Networking opportunities and personalized feedback

MO-DMDD-PH-Icon7

Mobile-optimized learning for anytime access

MO-DMDD-PH-Icon8

Structured grading and evaluation to track progress

Meet the Faculty

MICHAEL CIMA
Michael Cima

David H. Koch Professor of Engineering; Professor of Materials Science and Engineering, MIT David H. Koch Institute for Integrative Cancer Research; Faculty Director, Lemelson-MIT Program

Michael is the David H. Koch Professor of Engineering and a Professor of Materials Science and Engineering at the Massachusetts Institute of Technology at the David H. Koch In...

Guest Faculty

Antonio Ciaccia

Chief Executive Officer, 46brooklyn Research

Graham Lidgard

Chief Science Office (ret), Exact Science

Cynthia Gilbert

Patent Attorney, Blueshift IP, LLC

John Levinson

Cardiologist, Massachusetts General Hospital

Jeffrey Drazen

Parker B. Francis Distinguished Professor of Medicine, Harvard Medical School

Note: Guest faculty are subject to change.

Hear from Past Participants

I liked the format and thought that the majority of the videos were short, crisp, and very insightful. There were abundant resources which made it possible for us to go further. I have attended severa...
Manon Boisclair
Founder and CEO, InnovID B2
Both the content and format of the material were exactly what I was looking for in my goal to better understand the industry I serve.
Jonathan Kelly
Senior Software Development Engineer, Amazon Web Services
The best part of the program were the case studies from the instructors in the videos. These are comprehensive cases that include multiple topics and good illustrations to understand the concept.
Miaojun Wang
Senior Process Engineer, Applied Materials
It gave a quick overview of various medical product development and regulatory processes and development. People from various departments of pharma or biotech can use this for training.
Grace Kao
Senior Clinical Trial Physician, Bristol Myers Squibb
I learned from the experience of the interviewees. Their knowledge and professional experience were priceless in understanding the difficulties that can occur in drug and medical product development a...
Isabelle Viellard Pelve
Marketing Manager, DIH Technology Co.
The course was designed very nicely. I understand the great effort and hard work required to prepare this course and appreciate it. Overall, it gave an excellent overview and depth of the pharma indus...
Vikas Gujar
Customer Engineer Lead, Applied Materials
Example image of certificate that will be awarded upon successful completion of the program

Certificate

Get recognized! Upon successful completion of this program, you receive 4.8 Continuing Education Units (CEUs), a globally recognized measure of professional learning that reflects compliance with international quality standards, and a certificate of completion from MIT xPRO.

This program is graded as a pass or fail; participants must receive 75 percent to pass and obtain the certificate of completion.

After successful completion of the program, your verified digital certificate will be emailed to you, at no additional cost, in the name you used when registering for the program. All certificate images are for illustrative purposes only and may be subject to change at the discretion of MIT.

FAQs

How do I know if this program is right for me?

After reviewing the information on the program landing page, we recommend you submit the short form above to gain access to the program brochure, which includes more in-depth information. If you still have questions on whether this program is a good fit for you, please email learner.success@emeritus.org, and a dedicated program advisor will follow-up with you very shortly.

Are there any prerequisites for this program?

Some programs do have prerequisites, particularly the more technical ones. This information will be noted on the program landing page, as well as in the program brochure. If you are uncertain about program prerequisites and your capabilities, please email us at the ID mentioned above.

Note that, unless otherwise stated on the program web page, all programs are taught in English and proficiency in English is required.

What is the typical class profile?

More than 50 percent of our participants are from outside the United States. Class profiles vary from one cohort to the next, but, generally, our online certificates draw a highly diverse audience in terms of professional experience, industry, and geography — leading to a very rich peer learning and networking experience.

What other dates will this program be offered in the future?

Check back to this program web page or email us to inquire if future program dates or the timeline for future offerings have been confirmed yet.

How much time is required each week?

Each program includes an estimated learner effort per week. This is referenced at the top of the program landing page under the Duration section, as well as in the program brochure, which you can obtain by submitting the short form at the top of this web page.

How will my time be spent?

We have designed this program to fit into your current working life as efficiently as possible. Time will be spent among a variety of activities including:

  • Engaging with recorded video lectures from faculty

  • Attending webinars and office hours, as per the specific program schedule

  • Reading or engaging with examples of core topics

  • Completing knowledge checks/quizzes and required activities

  • Engaging in moderated discussion groups with your peers

  • Completing your final project, if required

The program is designed to be highly interactive while also allowing time for self-reflection and to demonstrate an understanding of the core topics through various active learning exercises. Please email us if you need further clarification on program activities.

What is it like to learn online with the learning collaborator, Emeritus?

More than 300,000 learners across 200 countries have chosen to advance their skills with Emeritus and its educational learning partners. In fact, 90 percent of the respondents of a recent survey across all our programs said that their learning outcomes were met or exceeded.

All the contents of the course would be made available to students at the commencement of the course. However, to ensure the program delivers the desired learning outcomes the students may appoint Emeritus to manage the delivery of the program in a cohort-based manner the cost of which is already included in the overall course fee of the course.

A dedicated program support team is available 24/5 (Monday to Friday) to answer questions about the learning platform, technical issues, or anything else that may affect your learning experience.

How do I interact with other program participants?

Peer learning adds substantially to the overall learning experience and is an important part of the program. You can connect and communicate with other participants through our learning platform.

What is the relationship between Emeritus and MIT xPRO?

Emeritus and MIT xPRO collaborate to create and deliver educational programs. None of these programs are Title IV-eligible.

What are the requirements to earn the certificate?

Each program includes an estimated learner effort per week, so you can gauge what will be required before you enroll. This is referenced at the top of the program landing page under the Duration section, as well as in the program brochure, which you can obtain by submitting the short form at the top of this web page. All programs are designed to fit into your working life.

This program is scored as a pass or no-pass; participants must complete the required activities to pass and obtain the certificate of completion. Some programs include a final project submission or other assignments to obtain passing status. This information will be noted in the program brochure. Please email us if you need further clarification on any specific program requirements.

What type of certificate will I receive?

Upon successful completion of the program, you will receive a smart digital certificate. The smart digital certificate can be shared with friends, family, schools, or potential employers. You can use it on your cover letter, resume, and/or display it on your LinkedIn profile.The digital certificate will be sent approximately two weeks after the program, once grading is complete.

Can I get the hard copy of the certificate?

No, only verified digital certificates will be issued upon successful completion. This allows you to share your credentials on social platforms such as LinkedIn, Facebook, and Twitter.

Do I receive alumni status after completing this program?

No, there is no alumni status granted for this program. In some cases, there are credits that count toward a higher level of certification. This information will be clearly noted in the program brochure.

How long will I have access to the learning materials?

You will have access to the online learning platform and all the videos and program materials for 24 months following the program start date. Access to the learning platform is restricted to registered participants per the terms of agreement.

What equipment or technical requirements are there for this program?

Participants will need the latest version of their preferred browser to access the learning platform. In addition, Microsoft Office and a PDF viewer are required to access documents, spreadsheets, presentations, PDF files, and transcripts.

Do I need to be online to access the program content?

Yes, the learning platform is accessed via the internet, and video content is not available for download. However, you can download files of video transcripts, assignment templates, readings, etc. For maximum flexibility, you can access program content from a desktop, laptop, tablet, or mobile device.

Video lectures must be streamed via the internet, and any livestream webinars and office hours will require an internet connection. However, these sessions are always recorded, so you may view them later.

Can I still register if the registration deadline has passed?

Yes, you can register up until seven days past the published start date of the program without missing any of the core program material or learnings.

What is the program fee, and what forms of payment do you accept?

The program fee is noted at the top of this program web page and usually referenced in the program brochure as well.

  • Flexible payment options are available (see details below as well as at the top of this program web page next to FEE).

  • Tuition assistance is available for participants who qualify. Please email learner.success@emeritus.org.

What if I don’t have a credit card? Is there another method of payment accepted?

Yes, you can do the bank remittance in the program currency via wire transfer or debit card. Please contact your program advisor, or email us for details.

I was not able to use the discount code provided. Can you help?

Yes! Please email us with the details of the program you are interested in, and we will assist you.

How can I obtain an invoice for payment?

Please email us your invoicing requirements and the specific program you’re interested in enrolling in.

Is there an option to make flexible payments for this program?

Yes, the flexible payment option allows a participant to pay the program fee in installments. This option is made available on the payment page and should be selected before submitting the payment.

How can I obtain a W9 form?

Please connect with us via email for assistance.

Who will be collecting the payment for the program?

Emeritus collects all program payments, provides learner enrollment and program support, and manages learning platform services.

Are there any restrictions on the types of funding that can be used to pay for the program?

Program fees for Emeritus programs with MIT xPRO may not be paid for with (a) funds from the GI Bill, the Post-9/11 Educational Assistance Act of 2008, or similar types of military education funding benefits or (b) Title IV financial aid funds.

What is the program refund and deferral policy?

For the program refund and deferral policy, please click the link here.

The Drug and Medical Device Development program from MIT xPRO is an eight-week learning journey that builds a strong foundation in the drug discovery and development lifecycle for the pharmaceutical and biotech industries — from concept to market launch.

Upon completion of the program, you will receive a digital certificate from MIT xPRO, demonstrating advanced, industry-relevant skills. This program does not offer any official pharmaceutical or drug development certification.

The Drug and Medical Device Development program from MIT xPRO is designed for working professionals in life sciences, pharmaceutical industry roles, and adjacent biotech industries looking to gain expertise in the drug development process, expand career prospects, or accelerate career advancement.

Professionals do not necessarily require a background in health sciences, pharmacy, or pharmaceutical sciences to enroll in the program. However, it can be beneficial in building specialized knowledge and a foundational understanding of preclinical testing, the clinical trial process, and drug application.

Global professionals can enroll in this MIT xPRO program and progress at their own pace. It also offers networking opportunities with peers worldwide and updates on the latest advancements shaping healthcare and biopharma sectors.

Many entry-level care credentials, including basic first aid/CPR or support-focused roles, can be earned in a matter of weeks. However, the Drug and Medical Device Development program offers advanced learning in the drug discovery and development process, granting a professional MIT xPRO certificate in eight weeks. It is not a clinical or regulatory medical certification.

Financing Options

Climb Credit*

We offer financing options with our partner, Climb Credit*. Click here to learn more.

*Applicable for US Residents

Flexible Payment Options For All

Flexible payment options allow you to pay the program fee in installments. Click here to see payment schedule.

Didn't find what you were looking for? Write to us at learner.success@emeritus.org or Schedule a call with one of our Program Advisors or call us at +1 401 443 9591 (US) / + 44 189 236 2347 (UK) / +65 3129 7174 (SG)

Flexible payment options available.

Starts On